1. National Center for Biotechnology Information. PubChem Compound Summary for CID 358641, Sulfamethoxazole and trimethoprim. https://pubchem.ncbi.nlm.nih.gov/compound/Sulfamethoxazole-and-trimethoprim. Accessed Mar. 12, 2022.
2. Ku SW, Jiamsakul A, Joshi K, Pasayan MKU, Widhani A, Chaiwarith R, Kiertiburanakul S, Avihingsanon A, Ly PS, Kumarasamy N, Do CD, Merati TP, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Khusuwan S, Sim BLH, Ng OT, Ratanasuwan W, Ross J, Wong WW; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. J Int AIDS Soc. 2019 Mar;22(3):e25264. doi: 10.1002/jia2.25264.
3. Medscape. Bactrim, Bactrim DS (trimethoprim/sulfamethoxazole) dosing, indications, interactions, adverse effects, and more. 2017.
4. MIMS. Sulfamethoxazole Trimethoprim. 2017.
5. FDA. Highlights of prescribing information BACTRIM (Sulfametoxazole and trimethropime) injection for intravenous use. 2017.
11. Therapeutic Good Administration. Product information Septrin. 2017. vol. 400, pp. 1-20.
13. Vachhani AV, Barvaliya M, Naik V, Jha P, Tripathi C. Effectiveness and tolerability of short course co-trimoxazole, norfloxacin and levofloxacin in bacteriological cure of uncomplicated urinary tract infection in outpatient setting. An open label, parallel group, randomized controlled trial. Infez Med. 2015 Jun;23(2):155-60.